{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:09:33Z","timestamp":1790179773710,"version":"4.1.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,1,28]]},"published-print":{"date-parts":[[2026,5]]},"DOI":"10.2967\/jnumed.125.271098","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:55:22Z","timestamp":1772124922000},"page":"765-772","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Paul C.","family":"Klauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Dehlavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Loor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Viray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besnik","family":"Qeriqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E.","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Zeglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena Y.","family":"Janjigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2026050105301226000_67.5.765.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"2026050105301226000_67.5.765.2","doi-asserted-by":"crossref","first-page":"e2118457","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global incidence and mortality of gastric cancer, 1980\u20132018","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw Open."},{"key":"2026050105301226000_67.5.765.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19104-6"},{"key":"2026050105301226000_67.5.765.4","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine."},{"key":"2026050105301226000_67.5.765.5","doi-asserted-by":"crossref","first-page":"23142","DOI":"10.1038\/s41598-021-02391-z","article-title":"Survival outcomes of management in metastatic gastric adenocarcinoma patients","volume":"11","author":"Hu","year":"2021","journal-title":"Sci Rep."},{"key":"2026050105301226000_67.5.765.6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10120-024-01479-5","article-title":"International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape","volume":"27","author":"Morgagni","year":"2024","journal-title":"Gastric Cancer."},{"key":"2026050105301226000_67.5.765.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09925-3"},{"key":"2026050105301226000_67.5.765.8","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1200\/JCO.2025.43.16_suppl.4021","article-title":"Claudin-18.2 expression in gastro-oesophageal adenocarcinoma in a Western population: overlap with other biomarkers and prognostic value [abstract]","volume":"43","author":"Herpe","year":"2025","journal-title":"J Clin Oncol."},{"key":"2026050105301226000_67.5.765.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1547"},{"key":"2026050105301226000_67.5.765.10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/cancers16030679","article-title":"Claudin 18.2 as a new biomarker in gastric cancer\u2014what should we know?","volume":"16","author":"Mathias-Machado","year":"2024","journal-title":"Cancers (Basel)."},{"key":"2026050105301226000_67.5.765.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00874-2"},{"key":"2026050105301226000_67.5.765.12","doi-asserted-by":"crossref","first-page":"155145","DOI":"10.1016\/j.prp.2024.155145","article-title":"Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: a literature review with expert opinion","volume":"254","author":"Angerilli","year":"2024","journal-title":"Pathol Res Pract."},{"key":"2026050105301226000_67.5.765.13","doi-asserted-by":"crossref","first-page":"17916","DOI":"10.1038\/s41598-024-68970-y","article-title":"The impact of CLDN18.2 expression on effector cells mediating antibody-dependent cellular cytotoxicity in gastric cancer","volume":"14","author":"Matsuishi","year":"2024","journal-title":"Sci Rep."},{"key":"2026050105301226000_67.5.765.14","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1038\/s41591-025-03783-8","article-title":"CLDN18.2-targeting antibody\u2013drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial","volume":"31","author":"Liu","year":"2025","journal-title":"Nat Med."},{"key":"2026050105301226000_67.5.765.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0508-4"},{"key":"2026050105301226000_67.5.765.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02465-7"},{"key":"2026050105301226000_67.5.765.17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00620-7"},{"key":"2026050105301226000_67.5.765.18","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.annonc.2024.08.1504","article-title":"First-line (1L) zolbetuximab + chemotherapy in patients (pts) with claudin 18.2 (CLDN18.2) +, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG\/GEJ) adenocarcinoma: a pooled final analysis of SPOTLIGHT + GLOW [abstract]","volume":"35(suppl 2)","author":"Kang","year":"2024","journal-title":"Ann Oncol."},{"key":"2026050105301226000_67.5.765.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026050105301226000_67.5.765.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026050105301226000_67.5.765.21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13550-021-00813-7","article-title":"Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example","volume":"11","author":"Huisman","year":"2021","journal-title":"EJNMMI Res."},{"key":"2026050105301226000_67.5.765.22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2326-6066.CIR-24-0138","article-title":"Preclinical development of T cells engineered to express a T cell antigen coupler (TAC) targeting claudin 18.2-positive solid tumors","volume":"13","author":"Xu","year":"2025","journal-title":"Cancer Immunol Res."},{"key":"2026050105301226000_67.5.765.23","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1038\/s41598-019-44874-0","article-title":"Targeting CLDN18.2 by CD3 bispecific and ADC modalities for the treatments of gastric and pancreatic cancer","volume":"9","author":"Zhu","year":"2019","journal-title":"Sci Rep."},{"key":"2026050105301226000_67.5.765.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1853"},{"key":"2026050105301226000_67.5.765.25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00019"},{"key":"2026050105301226000_67.5.765.26","first-page":"689","article-title":"Bone marrow dosimetry for radioimmunotherapy: theoretical considerations","volume":"34","author":"Sgouros","year":"1993","journal-title":"J Nucl Med"},{"key":"2026050105301226000_67.5.765.27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11307-023-01868-9","article-title":"MIB guides: preclinical radiopharmaceutical dosimetry","volume":"26","author":"Carter","year":"2024","journal-title":"Mol Imaging Biol."},{"key":"2026050105301226000_67.5.765.28","unstructured":"Frequently asked NSGTM questions. Jackson Laboratory website. https:\/\/www.jax.org\/jax-mice-and-services\/find-mice\/nsg-portfolio\/frequently-asked-nsg-questions. Accessed August 2, 2025."},{"key":"2026050105301226000_67.5.765.29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5230\/jgc.2025.25.e3","article-title":"Spatial and temporal tumor heterogeneity in gastric cancer: discordance of predictive biomarkers","volume":"25","author":"Lee","year":"2025","journal-title":"J Gastric Cancer."},{"key":"2026050105301226000_67.5.765.30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30408"},{"key":"2026050105301226000_67.5.765.31","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1021\/acs.molpharmaceut.1c00947","article-title":"Targeting claudin 18.2 using a highly specific antibody enables cancer diagnosis and guided surgery","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol Pharm."},{"key":"2026050105301226000_67.5.765.32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jpha.2023.02.011","article-title":"Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors","volume":"13","author":"Chen","year":"2023","journal-title":"J Pharm Anal."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:30:26Z","timestamp":1777638626000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.2967\/jnumed.125.271098"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271098","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}